Experimental gene therapy successfully revives immune systems in children with deadly disorder

A groundbreaking gene therapy has successfully restored immune function in children with ADA-SCID, a severe genetic disorder. Developed by international researchers, the treatment corrected faulty blood stem cells in 59 out of 62 young patients, offering a new lease on life. This innovative approach promises wider accessibility and is moving towards FDA approval, potentially transforming the future for affected children.